Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.06 +0.03 (+1.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Other Accumulated Expenses (2020 - 2022)

Updated

Acumen Pharmaceuticals' Other Accumulated Expenses was $37,000 in Q3 2022, down 68.9% from $119,000 a year earlier and down 63.4% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Other Accumulated Expenses (2020 - 2022) Analysis & Trends

At the end of FY2021, Other Accumulated Expenses at Acumen Pharmaceuticals came in at $204,000, up 126.7% from FY2020.

  • In earlier years, Other Accumulated Expenses was $90,000 in FY2020.
  • Per Business Quant data, ABOS's Other Accumulated Expenses in the three quarters before Q3 2022 was $101,000 (Q2 2022), $99,000 (Q1 2022) and $204,000 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,139.57 Bn 1,108.15 Bn 19.71 Bn
2 Johnson & Johnson 634.50 Bn 554.36 Bn 17.30 Bn
3 AbbVie 500.91 Bn 474.02 Bn 12.70 Bn
4 Merck 355.88 Bn 310.26 Bn 12.21 Bn
5 Novartis Ag 300.26 Bn 264.25 Bn 11.24 Bn
6 Astrazeneca 263.05 Bn 236.74 Bn 12.86 Bn
7 Amgen 237.74 Bn 193.14 Bn 7.24 Bn
8 Gilead Sciences 194.00 Bn 168.19 Bn 6.22 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn
10 Acumen Pharmaceuticals 136.92 Mn -345.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 37,000.00
Jun 30, 2022 101,000.00
Mar 31, 2022 99,000.00
Dec 31, 2021 204,000.00
Sep 30, 2021 119,000.00
Jun 30, 2021 52,000.00
Dec 31, 2020 90,000.00
API Access

Acumen Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ABOS&period=max&api_key=YOUR_API_KEY